The National Institute on Drug Abuse (NIDA), part of NIH, offers this Exploratory/Developmental Research Grant (R21) to investigate the multifaceted drug abuse aspects of HIV/AIDS. This funding supports research into drug-related risk behaviors, the interplay between addiction and HIV disease, and associated co-morbidities. Key areas of focus include identifying epidemiological shifts of HIV/AIDS among injection and non-injection drug users and their partners, developing and testing primary and secondary HIV prevention interventions, enhancing HIV testing, counseling, and treatment services, and exploring basic mechanisms of HIV infection and AIDS pathogenesis within the context of drug abuse and addiction. This grant aims to advance understanding and solutions for this critical public health challenge.
Opportunity ID: 202496
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PA-12-295 |
Funding Opportunity Title: | Drug Abuse Aspects of HIV/AIDS (R21) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Sep 25, 2012 |
Last Updated Date: | – |
Original Closing Date for Applications: | Jan 07, 2016 |
Current Closing Date for Applications: | Jan 07, 2016 |
Archive Date: | Feb 07, 2016 |
Estimated Total Program Funding: | – |
Award Ceiling: | $200,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | State governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Independent school districts Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Small businesses County governments For profit organizations other than small businesses Private institutions of higher education Special district governments |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), encourages Exploratory/Developmental Research Grant (R21) applications to examine the drug abuse aspects of HIV/AIDS, including research on drug-related risk behaviors, addiction and HIV disease, and drug use/HIV-related co-morbidities and consequences. Applications are needed to identify and predict changes in the epidemiology of HIV/AIDS among injection and non-injection drug users and among their sexual partners; to develop and test interventions for primary and secondary HIV prevention, including drug treatment interventions; to improve HIV testing, counseling, and treatment services for those living with HIV/AIDS; and to address basic mechanisms involved in HIV infection and AIDS pathogenesis in the context of drug abuse and addiction. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-12-295.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.279 | ADOBE-FORMS-B2 | Adobe-Forms-B2 | PKG00148052 | Apr 07, 2013 | Sep 24, 2013 | View |
93.279 | FORMS-C | Use for due dates after 9/24/2013 | PKG00181602 | Sep 16, 2013 | Jan 07, 2016 | View |
Package 1
Mandatory forms
202496 RR_SF424_1_2-1.2.pdf
202496 PerformanceSite_1_4-1.4.pdf
202496 RR_OtherProjectInfo_1_3-1.3.pdf
202496 RR_KeyPersonExpanded_1_2-1.2.pdf
202496 PHS398_CoverPageSupplement_1_4-1.4.pdf
202496 PHS398_ResearchPlan_1_3-1.3.pdf
202496 PHS398_Checklist_1_3-1.3.pdf
Optional forms
202496 RR_SubawardBudget30-1.2.pdf
202496 PHS398_ModularBudget_1_2-1.2.pdf
202496 RR_Budget-1.1.pdf
202496 PHS_CoverLetter_1_2-1.2.pdf
Package 2
Mandatory forms
202496 RR_SF424_2_0-2.0.pdf
202496 PHS398_ResearchPlan_2_0-2.0.pdf
202496 PHS398_CoverPageSupplement_2_0-2.0.pdf
202496 RR_KeyPersonExpanded_2_0-2.0.pdf
202496 RR_OtherProjectInfo_1_3-1.3.pdf
202496 PerformanceSite_2_0-2.0.pdf
Optional forms
202496 RR_SubawardBudget30_1_3-1.3.pdf
202496 PlannedReport-1.0.pdf
202496 PHS398_CumulativeInclusionReport-1.0.pdf
202496 PHS398_ModularBudget_1_2-1.2.pdf
202496 RR_Budget_1_3-1.3.pdf